MS HB1380

Establishes a Prescription Monitoring Program Advisory Committee to advise the Mississippi State Board of Pharmacy on aspects of the existing prescription monitoring program for controlled substances.

Committee membership includes up to 25 voting members representing medical, dental, nursing, pharmacy, law enforcement, and other health care and regulatory bodies, plus ex officio non-voting legislative members.

Committee shall meet at least quarterly and provide advice on program design, technology, monitored substances, funding sources, screening parameters, and best practices for prescribing and dispensing controlled substances.

Board of Pharmacy shall submit annual reports to the Legislature and Governor by November 30, incorporating advisory committee recommendations and statistical data from user agencies.

Section repeals on July 1, 2014, and the act takes effect July 1, 2012.